Lyka Labs logo

Lyka Labs share news, announcements and annual reports

NSE: LYKALABSBSE: 500259Pharmaceuticals & BiotechnologySmall Cap

Lyka Labs Limited · Face value ₹10 · Listed Jun 1986 on BSE, Feb 1995 on NSE
Last close ₹75.07down ₹1.53 (2.00%)BSE ₹75.50

Share price at the NSE close on 2 Nov 2026. Previous close ₹76.60.

2 Nov: open ₹76.00, high ₹76.00, low ₹75.07

52-week range of traded prices to 2 Nov 2026
₹44.10Low, 30 Mar 2026₹96.00High, 6 Nov 2025
Market cap
₹271 Cr2,310th largest listed
P/E
Lossover the last 12 months
P/B
2.83
Dividend yield
Nonein the last 12 months
ROE
−4.5%
ROCE
−3.6%
Debt to equity
0.47
Volume, NSE
15,895

Lyka Labs share news and announcements

1,493 announcements, routine notices left out, newest first. Page 25 of 30.

  1. Jul 2014

    • 14 Jul · Board meeting

    • 10 Jul · Shareholding Pattern For June 30, 2014

    • 3 Jul · Board meeting

      To consider : 1) Sale of factory at Tarapur. 2) To approve Notice for seeking approval of Shareholders through Postal Ballot. 3) Appointment of Scrutinizer for Postal Ballot. 4) To decide Calender of Events for Postal Ballot.
    • 3 Jul · Lyka Labs Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on July 14, 2014 to consider : 1. Sale of factory at Tarapur. 2. To approve ....

      Board Meeting on July 14, 2014
    • 2 Jul · Management

      Mr Yogesh B. Shah has been appointed as Chief Finance Officer (CFO) of the Company with effect from July 01, 2014.
    • 1 Jul · Lyka Labs Ltd has informed BSE that Mr. Yogesh B. Shah has been appointed as Chief Finance Officer (CFO) of the Company with effect from July 01, 2014.

      Appointment of Chief Finance Officer
  2. Jun 2014

  3. May 2014

  4. Apr 2014

  5. Mar 2014

    • 28 Mar · Board meeting

      Board of Directors of the Company at its meeting held on March 28, 2014, has decided the following : 1. To re-appoint Shri. N. I. Gandhi as Managing Director for a period of 5 years w.e.f. April 01, 2014 subject to approval of Shareholders in the General Meeting and other Statutory Approvals. 2. To invest in 35,00,000 Equity Shares of Rs. 10/- each of Lyka Exports Limited at a premium of Rs. 25/- in lieu of its outstanding subject to approval of the Shareholders in the General Meeting. 3. To transfer Domestic Marketing Division of Ethical products under Slump Sale to Lyka Healthcare Ltd a wholly owned subsidiary Company w.e.f. March 01, 2014.
    • 28 Mar · Lyka Labs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 28, 2014, has decided the following : 1. To re-appoint Shri. N. I. Gandhi as ....

      Outcome of the Board Meeting
  6. Feb 2014

  7. Nov 2013

  8. Oct 2013

  9. Sep 2013

  10. Aug 2013

  11. Jul 2013

  12. May 2013

  13. Apr 2013